Why the study?
Although hemolytic disorders are established causes of pulmonary arterial hypertension, their contribution to the global burden remains unclear.
Observational
Hemolysis-associated disorders, particularly G6PD trait and vitamin A deficiency, are strongly associated with the global incidence of pulmonary arterial hypertension, highlighting an underrecognized driver of the disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rebecca Lewandowski (2026) conducted an observational in Pulmonary arterial hypertension. Hemolysis-associated disorders was evaluated on Correlation between PAH age-standardized incidence rate and prevalence of hemoglobinopathies and hemolytic anemias (R = 0.61, p=7.70 × 10⁻²²).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: